Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹422.55
Market cap: ₹4,237 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.7×Sector 47.3×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Acquisition 4 Other Announcement 3 Merger & Restructuring 3 Management Change 2 Legal & Regulatory 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual General Meeting 2 Dividend 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 20:12 IST BSE

Merger & Restructuring

Gufic BioSciences Merger & Restructuring Worth ₹0.24 Cr

Gufic Biosciences will incorporate a new subsidiary, Gufic Philippines Inc, for ₹0.24 Crore. The entity will support the company's pharmaceutical business expansion in the Philippines.

Value: ₹0.24 Cr

Read the filing ↗

14 Aug 2026 20:11 IST NSE

Merger & Restructuring

Gufic BioSciences Merger & Restructuring Worth ₹2.4 Cr

Gufic Biosciences will incorporate a new subsidiary, Gufic Philippines Inc., to expand pharmaceutical distribution. The company approved a cash investment of approximately ₹2.4 Crore.

Value: ₹2.40 Cr

Read the filing ↗

14 Aug 2026 19:53 IST NSE

Merger & Restructuring

Gufic BioSciences Merger & Restructuring Worth ₹2.38 Cr

Gufic Biosciences will incorporate a subsidiary, 'Gufic Philippines Inc.', investing up to USD 250,000 (~₹2.38 Crore) to expand pharmaceutical operations in the Philippines.

Value: ₹2.38 Cr

Read the filing ↗